相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Angiotensin II Type 1 Receptor-Dependent Oxidative Stress Mediates Endothelial Dysfunction in Type 2 Diabetic Mice
Wing Tak Wong et al.
ANTIOXIDANTS & REDOX SIGNALING (2010)
Telmisartan improves endothelial dysfunction and renal autoregulation in Dahl salt-sensitive rats
Minoru Satoh et al.
HYPERTENSION RESEARCH (2010)
Antidiabetic drug pioglitazone protects the heart via activation of PPAR-γ receptors, PI3-kinase, Akt, and eNOS pathway in a rabbit model of myocardial infarction
Shinji Yasuda et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Thromboxane prostanoid receptor activation impairs endothelial nitric oxide-dependent vasorelaxations: The role of Rho kinase
Cui Qing Liu et al.
BIOCHEMICAL PHARMACOLOGY (2009)
Cyclooxygenase-2-Derived Prostaglandin F2α Mediates Endothelium-Dependent Contractions in the Aortae of Hamsters With Increased Impact During Aging
Siu Ling Wong et al.
CIRCULATION RESEARCH (2009)
Inhibition of Tumor Necrosis Factor-α-Induced Interleukin-6 Expression by Telmisartan Through Cross-Talk of Peroxisome Proliferator-Activated Receptor-γ With Nuclear Factor κB and CCAAT/Enhancer- Binding Protein-β
Qingping Tian et al.
HYPERTENSION (2009)
Oxidative stress and cardiovascular disease: Novel tools give (free) radical insight
Ian M. Fearon et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2009)
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Philip D. Home et al.
LANCET (2009)
Meta-analysis of randomized controlled trials comparing telmisartan with losartan in the treatment of patients with hypertension
Gui-Lin Xi et al.
AMERICAN JOURNAL OF HYPERTENSION (2008)
Pioglitazone ameliorates endothelial dysfunction and restores ischemia-induced angiogenesis in diabetic mice
Po-Hsun Huang et al.
BIOMEDICINE & PHARMACOTHERAPY (2008)
The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: A retrospective analysis of 50 studies
Helmut Schumacher et al.
BLOOD PRESSURE (2008)
Peroxisome proliferator-activated receptor-γ-mediated effects in the vasculature
Sheng Zhong Duan et al.
CIRCULATION RESEARCH (2008)
AT(1)-receptor blockade by telmisartan upregulates GTP-cyclohydrolase I and protects eNOS in diabetic rats
Philip Wenzel et al.
FREE RADICAL BIOLOGY AND MEDICINE (2008)
Interference with PPARγ signaling causes cerebral vascular dysfunction, hypertrophy, and remodeling
Andreas M. Beyer et al.
HYPERTENSION (2008)
Effect of telmisartan on nitric oxide-asymmetrical dimethylarginine system -: Role of angiotensin II type 1 receptor and peroxisome proliferator activated receptor γ signaling during endothelial aging
Fortunato Scalera et al.
HYPERTENSION (2008)
Oxidative stress in vascular disease:: causes, defense mechanisms and potential therapies
Ulrich Foerstermann
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2008)
Altered TP receptor function in isolated, perfused kidneys of nondiabetic and diabetic ApoE-deficient mice
Frederic Michel et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
Rosiglitazone evaluated for cardiovascular outcomes - An interim analysis
Philip D. Home et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
The PPARγ ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice
Jinah Hwang et al.
VASCULAR PHARMACOLOGY (2007)
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors
Philippe Gervois et al.
NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM (2007)
Involvement of thromboxane A(2) receptor in the cerebrovascular damage of salt-loaded, stroke-prone rats
Toshiaki Ishizuka et al.
JOURNAL OF HYPERTENSION (2007)
Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation:: novel mechanism for PPARγ agonist's effects on edema and weight gain
Konstantinos B. Sotiropoulos et al.
FASEB JOURNAL (2006)
Peroxisome proliferator-activated receptor γ ligands stimulate endothelial nitric oxide production through distinct peroxisome proliferator-activated receptor γ-dependent mechanisms
JA Polikandriotis et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Significance of angiotensin II receptor blocker lipophilicities and their protective effect against vascular remodeling
S Takai et al.
HYPERTENSION RESEARCH (2005)
Nitric oxide production and regulation of endothelial nitric-oxide synthase phosphorylation by prolonged treatment with troglitazone -: Evidence for involvement of peroxisome proliferator-activated receptor (PPAR)γ-dependent and PPARγ-independent signaling pathways
DH Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Antidiabetic mechanisms of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists: beyond the renin-angiotensin system
TW Kurtz et al.
JOURNAL OF HYPERTENSION (2004)
Safety of telmisartan in patients with arterial hypertension - An open-label observational study
MC Michel et al.
DRUG SAFETY (2004)
Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-α activity
M Schupp et al.
CIRCULATION (2004)
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity
SC Benson et al.
HYPERTENSION (2004)
Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release
J Fontana et al.
CIRCULATION RESEARCH (2002)
PPARγ:: a nuclear regulator of metabolism, differentiation, and cell growth
ED Rosen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation
MB Harris et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Endothelial dysfunction in cardiovascular diseases - The role of oxidant stress
H Cai et al.
CIRCULATION RESEARCH (2000)
Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation
G Chinetti et al.
INFLAMMATION RESEARCH (2000)
分享论文
